V. A. Moyer and U. S. , Preventive Services Task Force. Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement, Ann Intern Med, vol.160, issue.6, pp.414-434, 2014.

C. Durnwald, Gestational diabetes: Linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome, Semin Perinatol, vol.39, issue.4, pp.254-262, 2015.

L. R. Mack and P. G. Tomich, Gestational Diabetes, Obstet Gynecol Clin North Am, vol.44, issue.2, pp.207-224, 2017.

D. Farrar, Hyperglycemia in pregnancy: prevalence, impact, and management challenges, Int J Womens Health, vol.8, pp.519-546, 2016.

M. E. Moretti, M. Rezvani, and G. Koren, Safety of Glyburide for Gestational Diabetes: A Meta-Analysis of Pregnancy Outcomes, Ann Pharmacother, vol.42, issue.4, pp.483-90, 2008.

N. Poolsup, N. Suksomboon, and M. Amin, Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. Hribal ML, editor. PLoS One, vol.9, p.109985, 2014.

Y. Zeng, M. Li, Y. Chen, L. Jiang, S. Wang et al., The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis, Adv Med Sci, vol.59, issue.1, pp.95-101, 2014.

R. Song, L. Chen, Y. Chen, X. Si, Y. Liu et al., Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis, vol.12, p.182488, 2017.

Y. Jiang, X. Chen, T. Ding, X. Wang, Z. Zhu et al., Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials, J Clin Endocrinol Metab, vol.100, issue.5, pp.2071-80, 2015.

M. Balsells, A. Garcia-patterson, I. Sola, M. Roque, I. Gich et al., Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis, BMJ, 2015.

M. Sé-nat, H. Affres, A. Letourneau, M. Coustols-valat, M. Cazaubiel et al., Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes, JAMA, vol.319, issue.17, p.1773, 2018.

O. Langer, D. L. Conway, M. D. Berkus, E. Xenakis, and O. Gonzales, A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus, N Engl J Med, vol.343, issue.16, pp.1134-1142, 2000.

M. Hebert, X. Ma, S. Naraharisetti, K. Krudys, J. Umans et al., Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice. Clin Pharmacol Ther, vol.85, pp.607-621, 2009.

R. A. Schwartz, B. Rosenn, K. Aleksa, and G. Koren, Glyburide transport across the human placenta, Obstet Gynecol, vol.125, issue.3, pp.583-591, 2015.

Z. Mohamed, V. B. Arya, and K. Hussain, Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management, J Clin Res Pediatr Endocrinol, vol.4, issue.4, pp.169-81, 2012.

N. Li, Y. Deng, D. Wang, Y. Qiao, and F. Li, Determination of glibenclamide and puerarin in rat plasma by UPLC-MS/MS: application to their pharmacokinetic interaction study, Talanta, vol.30, pp.109-124, 2013.

P. Bourget, H. Fernandez, S. Demirdjian, C. Delouis, and R. Frydman, Determination of the ratio of serum concentrations of tobramycin between fetus and mother at birth. A model of small scale pharmacokinetics

, Arch Fr Pediatr, vol.48, issue.8, pp.543-550, 1991.

P. Royston and W. Sauerbrei, Multivariable model-building. A pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables, 2008.

. Statacorp, Stata Statistical Software: Release 14. College Station, 2015.

R. Malek and S. N. Davis, Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus, Expert Opin Drug Metab Toxicol, vol.12, issue.6, pp.691-700, 2016.

B. D. Prendergast, Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents, Clin Pharm, vol.3, issue.5, pp.473-85, 1984.

J. Kirchheiner, J. Brockmöller, I. Meineke, S. Bauer, W. Rohde et al., Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers, Clin Pharmacol Ther, vol.71, issue.4, pp.286-96, 2002.

J. Kraemer, J. Klein, A. Lubetsky, and G. Koren, Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety, Am J Obstet Gynecol, vol.195, issue.1, pp.270-274, 2005.

C. Gedeon, G. Anger, M. Piquette-miller, and G. Koren, Breast Cancer Resistance Protein: Mediating the Trans-placental Transfer of Glyburide across the Human Placenta, Placenta, vol.29, issue.1, pp.39-43, 2008.

E. Pollex, A. Lubetsky, and G. Koren, The Role of Placental Breast Cancer Resistance Protein in the Efflux of Glyburide across the Human Placenta, Placenta, vol.29, issue.8, pp.743-750, 2008.

D. L. Shuster, L. J. Risler, B. Prasad, J. C. Calamia, J. L. Voellinger et al., Identification of CYP3A7 for glyburide metabolism in human fetal livers, Biochem Pharmacol, vol.92, issue.4, pp.690-700, 2014.